Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Publikationen

Suchbegriffe: SARCOMA - GENETICS , . Treffer: 21

2017

Cuppens, T; Annibali, D; Coosemans, A; Trovik, J; Ter Haar, N; Colas, E; Garcia-Jimenez, A; Van de Vijver, K; Kruitwagen, RP; Brinkhuis, M; Zikan, M; Dundr, P; Huvila, J; Carpén, O; Haybaeck, J; Moinfar, F; Salvesen, HB; Stukan, M; Mestdagh, C; Zweemer, RP; Massuger, LF; Mallmann, MR; Wardelmann, E; Mints, M; Verbist, G; Thomas, D; Gommé, E; Hermans, E; Moerman, P; Bosse, T; Amant, F Potential Targets' Analysis Reveals Dual PI3K/mTOR Pathway Inhibition as a Promising Therapeutic Strategy for Uterine Leiomyosarcomas-an ENITEC Group Initiative.
Clin Cancer Res. 2017; 23(5):1274-1285 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Heitzer, E; Sunitsch, S; Gilg, MM; Lohberger, B; Rinner, B; Kashofer, K; Stündl, N; Ulz, P; Szkandera, J; Leithner, A; Liegl-Atzwanger, B Expanded molecular profiling of myxofibrosarcoma reveals potentially actionable targets.
Mod Pathol. 2017; 30(12):1698-1709 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Lohberger, B; Stuendl, N; Leithner, A; Rinner, B; Sauer, S; Kashofer, K; Liegl-Atzwanger, B Establishment of a novel cellular model for myxofibrosarcoma heterogeneity.
Sci Rep. 2017; 7(9):44700-44700 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Smolle, MA; Leithner, A; Posch, F; Szkandera, J; Liegl-Atzwanger, B; Pichler, M MicroRNAs in Different Histologies of Soft Tissue Sarcoma: A Comprehensive Review.
Int J Mol Sci. 2017; 18(9): [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Szurian, K; Kashofer, K; Liegl-Atzwanger, B Role of Next-Generation Sequencing as a Diagnostic Tool for the Evaluation of Bone and Soft-Tissue Tumors.
Pathobiology. 2017; 84(6):323-338 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2016

Liegl-Atzwanger, B; Heitzer, E; Flicker, K; Müller, S; Ulz, P; Saglam, O; Tavassoli, F; Devouassoux-Shisheboran, M; Geigl, J; Moinfar, F Exploring chromosomal abnormalities and genetic changes in uterine smooth muscle tumors.
Mod Pathol. 2016; 29(10):1262-1277 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2015

Flicker, K; Smolle, E; Haybaeck, J; Moinfar, F Genomic characterization of endometrial stromal sarcomas with array comparative genomic hybridization.
Exp Mol Pathol. 2015; 98(3):367-374
Web of Science PubMed FullText FullText_MUG

 

Murali, R; Chandramohan, R; Möller, I; Scholz, SL; Berger, M; Huberman, K; Viale, A; Pirun, M; Socci, ND; Bouvier, N; Bauer, S; Artl, M; Schilling, B; Schimming, T; Sucker, A; Schwindenhammer, B; Grabellus, F; Speicher, MR; Schaller, J; Hillen, U; Schadendorf, D; Mentzel, T; Cheng, DT; Wiesner, T; Griewank, KG Targeted massively parallel sequencing of angiosarcomas reveals frequent activation of the mitogen activated protein kinase pathway.
Oncotarget. 2015; 6(34):36041-36052 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2014

Fröhlich, LF; Mrakovcic, M; Smole, C; Lahiri, P; Zatloukal, K Epigenetic silencing of apoptosis-inducing gene expression can be efficiently overcome by combined SAHA and TRAIL treatment in uterine sarcoma cells.
PLoS One. 2014; 9(3):e91558-e91558 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Ugurel, S; Mentzel, T; Utikal, J; Helmbold, P; Mohr, P; Pföhler, C; Schiller, M; Hauschild, A; Hein, R; Kämpgen, E; Kellner, I; Leverkus, M; Becker, JC; Ströbel, P; Schadendorf, D Neoadjuvant imatinib in advanced primary or locally recurrent dermatofibrosarcoma protuberans: a multicenter phase II DeCOG trial with long-term follow-up.
Clin Cancer Res. 2014; 20(2):499-510 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2013

Szkandera, J; Absenger, G; Liegl-Atzwanger, B; Pichler, M; Stotz, M; Gerger, S; Zacherl, M; Renner, W; Haijun, M; Leithner, A; Gerger, A Common gene variants in RAD51, XRCC2 and XPD are not associated with clinical outcome in soft-tissue sarcoma patients.
Cancer Epidemiol. 2013; 37(6):1003-1009
Web of Science PubMed FullText FullText_MUG

 

2012

Kretschmer, N; Rinner, B; Stuendl, N; Kaltenegger, H; Wolf, E; Kunert, O; Boechzelt, H; Leithner, A; Bauer, R; Lohberger, B Effect of costunolide and dehydrocostus lactone on cell cycle, apoptosis, and ABC transporter expression in human soft tissue sarcoma cells.
Planta Med. 2012; 78(16):1749-1756 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Wang, WL; Evans, HL; Meis, JM; Liegl-Atzwanger, B; Bovee, JVMG; Goldblum, JR; Billings, SD; Rubin, BP; Lopez-Terrada, D; Lazar, AJ; FUS rearrangements are rare in 'pure' sclerosing epithelioid fibrosarcoma.
Mod Pathol. 2012; 25(6):846-853 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2011

Kitz, K; Windischhofer, W; Leis, HJ; Huber, E; Kollroser, M; Malle, E 15-Deoxy-Δ12,14-prostaglandin J2 induces Cox-2 expression in human osteosarcoma cells through MAPK and EGFR activation involving reactive oxygen species.
Free Radic Biol Med. 2011; 50(7):854-865
Web of Science PubMed FullText FullText_MUG

 

2008

Clifford, N; Smith, LM; Powell, J; Gattenlohner, S; Marx, A; O'Connor, R The EphA3 receptor is expressed in a subset of rhabdomyosarcoma cell lines and suppresses cell adhesion and migration.
J Cell Biochem. 2008; 105(5):1250-1259
Web of Science PubMed FullText FullText_MUG

 

Kovacevic, A; Hammer, A; Stadelmeyer, E; Windischhofer, W; Sundl, M; Ray, A; Schweighofer, N; Friedl, G; Windhager, R; Sattler, W; Malle, E Expression of serum amyloid A transcripts in human bone tissues, differentiated osteoblast-like stem cells and human osteosarcoma cell lines.
J Cell Biochem. 2008; 103(3): 994-1004. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2007

Ugurel, S Targeted therapy of dermatofibrosarcoma with imatinib.
J Dtsch Dermatol Ges. 2007; 5(3):261-261
PubMed FullText FullText_MUG

 

2006

Cam, H; Griesmann, H; Beitzinger, M; Hofmann, L; Beinoraviciute-Kellner, R; Sauer, M; Huttinger-Kirchhof, N; Oswald, C; Friedl, P; Gattenlohner, S; Burek, C; Rosenwald, A; Stiewe, T p53 family members in myogenic differentiation and rhabdomyosarcoma development.
Cancer Cell. 2006; 10(4):281-293 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Gattenlohner, S; Marx, A; Markfort, B; Pscherer, S; Landmeier, S; Juergens, H; Muller-Hermelink, HK; Matthews, I; Beeson, D; Vincent, A; Rossig, C Rhabdomyosarcoma lysis by T cells expressing a human autoantibody-based chimeric receptor targeting the fetal acetylcholine receptor.
Cancer Res. 2006; 66(1):24-28 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2004

Hrzenjak, A; Tippl, M; Kremser, ML; Strohmeier, B; Guelly, C; Neumeister, D; Lax, S; Moinfar, F; Tabrizi, AD; Isadi-Moud, N; Zatloukal, K; Denk, H Inverse correlation of secreted frizzled-related protein 4 and beta-catenin expression in endometrial stromal sarcomas.
J PATHOL. 2004; 204(1): 19-27.
Web of Science PubMed FullText FullText_MUG

 

1999

Gattenloehner, S; Dockhorn-Dworniczak, B; Leuschner, I; Vincent, A; Muller-Hermelink, HK; Marx, A A comparison of MyoD1 and fetal acetylcholine receptor expression in childhood tumors and normal tissues: implications for the molecular diagnosis of minimal disease in rhabdomyosarcomas.
J Mol Diagn. 1999; 1(1):23-31 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

© Med Uni Graz Impressum